Cargando…

Cannabinoids, reward processing, and psychosis

BACKGROUND: Evidence suggests that an overlap exists between the neurobiology of psychotic disorders and the effects of cannabinoids on neurocognitive and neurochemical substrates involved in reward processing. AIMS: We investigate whether the psychotomimetic effects of delta-9-tetrahydrocannabinol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunasekera, Brandon, Diederen, Kelly, Bhattacharyya, Sagnik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110536/ https://www.ncbi.nlm.nih.gov/pubmed/33644820 http://dx.doi.org/10.1007/s00213-021-05801-2

Ejemplares similares

Cannabinoid disruption of learning mechanisms involved in reward processing
por: Lupica, Carl R., et al.
Publicado: (2018)

Neural Circuitry of Salience and Reward Processing in Psychosis
por: Kesby, James P., et al.
Publicado: (2021)

Neuroimaging Evidence for Cannabinoid Modulation of Cognition and Affect in Man
por: Bhattacharyya, Sagnik, et al.
Publicado: (2012)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

17. CANNABIDIOL AS A TREATMENT IN DIFFERENT STAGES OF PSYCHOSIS- EFFICACY AND MECHANISMS
por: Bhattacharyya, Sagnik
Publicado: (2018)

F102. CHANGE IN PATTERNS OF CANNABIS AND OTHER SUBSTANCE USE OVER TIME IN EARLY PSYCHOSIS- EXAMINING THE EFFECT OF DEVELOPMENT OF PSYCHOSIS
por: Sami, Musa, et al.
Publicado: (2018)

The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System
por: Colizzi, Marco, et al.
Publicado: (2022)

Cortical and Striatal Reward Processing in Parkinson’s Disease Psychosis
por: Garofalo, Sara, et al.
Publicado: (2017)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
por: Colizzi, Marco, et al.
Publicado: (2020)

The Placebo Effect in Psychosis: Why It Matters and How to Measure It
por: Hird, Emily J., et al.
Publicado: (2023)

PM298. Dissociable effects of cannabinoids on anticipatory and consummatory reward processing
por: Freeman, Tom P, et al.
Publicado: (2016)

Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions 
por: Spanagel, Rainer
Publicado: (2020)

A Comparison of Cognitive Performance in Patients With Parkinson's Disease Psychosis According to Psychosis Severity: A Meta-Analysis
por: Gosse, Luca, et al.
Publicado: (2023)

Scaling prediction errors to reward variability benefits error-driven learning in humans
por: Diederen, Kelly M. J., et al.
Publicado: (2015)

Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis
por: Velayudhan, Latha, et al.
Publicado: (2021)

T145. EFFECTS OF CANNABIDIOL ON EMOTION PROCESSING IN PSYCHOSIS RISK: AN FMRI INVESTIGATION
por: Davies, Cathy, et al.
Publicado: (2020)

The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task
por: Wilson, Robin Paul, et al.
Publicado: (2018)

Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis
por: Wotruba, Diana, et al.
Publicado: (2014)

Cannabidiol modulation of hippocampal glutamate in early psychosis
por: O’Neill, Aisling, et al.
Publicado: (2021)

Human Striatal Response to Reward Anticipation Linked to Hippocampal Glutamate Levels
por: Bossong, Matthijs G, et al.
Publicado: (2018)

O5.2. CBD MODULATION OF HIPPOCAMPAL GLUTAMATE IN PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2020)

Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
por: Wilson, Robin, et al.
Publicado: (2019)

Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence
por: Bortoletto, Riccardo, et al.
Publicado: (2023)

The neural mechanisms of social reward in early psychosis
por: Fett, Anne-Kathrin J, et al.
Publicado: (2019)

Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB(1) Receptors: A Step Back into the Future
por: Panagis, George, et al.
Publicado: (2014)

Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
por: Befort, Katia
Publicado: (2015)

Reward Learning, Neurocognition, Social Cognition, and Symptomatology in Psychosis
por: Lewandowski, Kathryn E., et al.
Publicado: (2016)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
por: Colizzi, Marco, et al.
Publicado: (2019)

Cannabinoid Control of Olfactory Processes: The Where Matters
por: Terral, Geoffrey, et al.
Publicado: (2020)

Natural Language Processing markers in first episode psychosis and people at clinical high-risk
por: Morgan, Sarah E., et al.
Publicado: (2021)

S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2018)

The effect of cannabis use on memory function: an update
por: Schoeler, Tabea, et al.
Publicado: (2013)

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
por: Davies, Cathy, et al.
Publicado: (2020)

17.3 EFFECT OF CANNABIDIOL ON SYMPTOMS, DISTRESS AND NEUROPHYSIOLOGICAL ABNORMALITIES IN CLINICAL HIGH-RISK FOR PSYCHOSIS PATIENTS: A PLACEBO-CONTROLLED STUDY
por: Bhattacharyya, Sagnik, et al.
Publicado: (2018)

O3.3. REWARD PROCESSING AS A VULNERABILITY INDICATOR FOR PSYCHOSIS: RESULTS FROM A TWIN STUDY
por: Nielsen, Mette, et al.
Publicado: (2018)

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

Emerging synthetic cannabinoids and the risk of psychosis: a growing concern for public health
por: Souza, José Diogo R., et al.
Publicado: (2023)

Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
por: Schoeler, Tabea, et al.
Publicado: (2017)

Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
por: Sami, Musa Basseer, et al.
Publicado: (2018)

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
por: Bhattacharyya, Sagnik, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9p7eshi1vthlin96sb0i9g3tqi